The underlying mechanism of this functional reversal may involve multidimensional regulation, such as differential methylation or histone modification of the KLF9 target gene promoter in primary and metastatic lesions; Differences in paracrine signaling pathways and spatiotemporal specific switching of KLF9 protein interaction network in tumor associated cells. This evidence concerns the gene KLF9 and neoplasm.